Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 471

1.

Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.

Dolan KA, Shearer J, White B, Zhou J, Kaldor J, Wodak AD.

Addiction. 2005 Jun;100(6):820-8.

PMID:
15918812
2.

Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan.

Huang YF, Kuo HS, Lew-Ting CY, Tian F, Yang CH, Tsai TI, Gange SJ, Nelson KE.

Addiction. 2011 Aug;106(8):1437-45. doi: 10.1111/j.1360-0443.2011.03443.x.

PMID:
21438941
3.

Effect of methadone treatment on incarceration rates among injection drug users.

Werb D, Kerr T, Marsh D, Li K, Montaner J, Wood E.

Eur Addict Res. 2008;14(3):143-9. doi: 10.1159/000130418.

PMID:
18552490
4.

The effect of time spent in treatment and dropout status on rates of convictions, cautions and imprisonment over 5 years in a primary care-led methadone maintenance service.

Oliver P, Keen J, Rowse G, Ewins E, Griffiths L, Mathers N.

Addiction. 2010 Apr;105(4):732-9. doi: 10.1111/j.1360-0443.2009.02856.x.

PMID:
20403022
5.

Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.

Kerr T, Marsh D, Li K, Montaner J, Wood E.

Drug Alcohol Depend. 2005 Dec 12;80(3):329-35.

PMID:
15964714
6.

A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system.

Dolan KA, Shearer J, MacDonald M, Mattick RP, Hall W, Wodak AD.

Drug Alcohol Depend. 2003 Oct 24;72(1):59-65.

PMID:
14563543
7.

Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002.

Bell J, Burrell T, Indig D, Gilmour S.

Drug Alcohol Depend. 2006 Jan 4;81(1):55-61.

PMID:
15993552
8.

Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.

Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS.

Drug Alcohol Depend. 2006 Sep 15;84(2):188-94.

PMID:
16542797
9.

Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.

Brugal MT, Domingo-Salvany A, Puig R, Barrio G, García de Olalla P, de la Fuente L.

Addiction. 2005 Jul;100(7):981-9.

PMID:
15955014
10.

Value for money in drug treatment: economic evaluation of prison methadone.

Warren E, Viney R, Shearer J, Shanahan M, Wodak A, Dolan K.

Drug Alcohol Depend. 2006 Sep 15;84(2):160-6.

PMID:
16487668
11.

Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.

Suntharasamai P, Martin M, Vanichseni S, van Griensven F, Mock PA, Pitisuttithum P, Tappero JW, Sangkum U, Kitayaporn D, Gurwith M, Choopanya K; Bangkok Vaccine Evaluation Group..

Addiction. 2009 Feb;104(2):235-42. doi: 10.1111/j.1360-0443.2008.02436.x.

PMID:
19149819
12.

Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.

Ngo HT, Tait RJ, Hulse GK.

Arch Gen Psychiatry. 2008 Apr;65(4):457-65. doi: 10.1001/archpsyc.65.4.457.

PMID:
18391134
13.

Low risk for hepatitis C seroconversion in methadone maintenance treatment.

Peles E, Schreiber S, Rados V, Adelson M.

J Addict Med. 2011 Sep;5(3):214-20. doi: 10.1097/ADM.0b013e31820e13dd.

PMID:
21844836
14.

Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.

Larney S, Toson B, Burns L, Dolan K.

Addiction. 2012 Feb;107(2):372-80. doi: 10.1111/j.1360-0443.2011.03618.x.

PMID:
21851442
15.

A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences.

Jimenez-Treviño L, Saiz PA, García-Portilla MP, Díaz-Mesa EM, Sánchez-Lasheras F, Burón P, Casares MJ, Marina P, Gutiérrez E, Bobes J.

Addict Behav. 2011 Dec;36(12):1184-90. doi: 10.1016/j.addbeh.2011.07.019.

PMID:
21835551
16.

[Factors influencing the rate on retention to methadone maintenance treatment program among heroin addicts in Guizhou, China].

Liang T, Liu EW, Zhong H, Wang B, Shen LM, Wu ZL.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Feb;30(2):131-5. Chinese.

PMID:
19565871
17.

Drug use and injection risk-taking among prison methadone maintenance patients.

Darke S, Kaye S, Finlay-Jones R.

Addiction. 1998 Aug;93(8):1169-75.

PMID:
9813898
18.

Deaths in methadone maintenance treatment in New South Wales, Australia 1990-1995.

Zador D, Sunjic S.

Addiction. 2000 Jan;95(1):77-84.

PMID:
10723832
19.

An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam.

Buster MC, van Brussel GH, van den Brink W.

Addiction. 2002 Aug;97(8):993-1001.

PMID:
12144602
20.

The effect of a jail methadone maintenance therapy (MMT) program on inmate recidivism.

McMillan GP, Lapham S, Lackey M.

Addiction. 2008 Dec;103(12):2017-23. doi: 10.1111/j.1360-0443.2008.02361.x.

PMID:
19469745
Items per page

Supplemental Content

Support Center